Correction: Role of novel histone modifications in cancer

Muthu K Shanmugam¹, Frank Arfuso², Surendar Arumugam³, Arunachalam Chinnathambi⁴, Jinsong Bian¹, Sudha Warrier⁵, Ling Zhi Wang^{1

6}, Alan Prem Kumar^{1

6

7

8

9}, Kwang Seok Ahn¹⁰, Gautam Sethi¹, Manikandan Lakshmanan^{3

11}

Affiliations

¹ Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
² Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia.
³ Institute of Molecular and Cell Biology, ASTAR, Biopolis Drive, Proteos, Singapore, Singapore.
⁴ Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
⁵ Division of Cancer Stem Cells and Cardiovascular Regeneration, School of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India.
⁶ Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
⁷ Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
⁸ National University Cancer Institute, National University Health System, Singapore, Singapore.
⁹ Department of Biological Sciences, University of North Texas, Denton, Texas, USA.
¹⁰ College of Korean Medicine, Kyung Hee University, Dongdaemun-gu, Seoul, Korea.
¹¹ Department of Pathology, National University Hospital Singapore, Singapore, Singapore.

Published Erratum

Muthu K Shanmugam et al. Oncotarget. 2018.

. 2018 Apr 10;9(27):19460.

doi: 10.18632/oncotarget.25152.

¹ Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
² Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia.
³ Institute of Molecular and Cell Biology, ASTAR, Biopolis Drive, Proteos, Singapore, Singapore.
⁴ Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
⁵ Division of Cancer Stem Cells and Cardiovascular Regeneration, School of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India.
⁶ Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
⁷ Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
⁸ National University Cancer Institute, National University Health System, Singapore, Singapore.
⁹ Department of Biological Sciences, University of North Texas, Denton, Texas, USA.
¹⁰ College of Korean Medicine, Kyung Hee University, Dongdaemun-gu, Seoul, Korea.
¹¹ Department of Pathology, National University Hospital Singapore, Singapore, Singapore.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.23356.].

Role of novel histone modifications in cancer.
Shanmugam MK, Arfuso F, Arumugam S, Chinnathambi A, Jinsong B, Warrier S, Wang LZ, Kumar AP, Ahn KS, Sethi G, Lakshmanan M. Shanmugam MK, et al. Oncotarget. 2017 Dec 17;9(13):11414-11426. doi: 10.18632/oncotarget.23356. eCollection 2018 Feb 16. Oncotarget. 2017. PMID: 29541423 Free PMC article. Review.